Antibacterial activity of lysozyme‐chitosan oligosaccharide conjugates on two periodontal bacteria
Oral Diseases · 2024
DOI: 10.1111/odi.14710 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2024. Verfasst von Yasuo Takeuchi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan. Hauptthemen laut MEDLINE: Muramidase, Chitosan, Porphyromonas gingivalis, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Wako Filter Technology Co., Ltd..
Abstract (Originalsprache)
Objective
This study aimed to evaluate the in vitro antibacterial effects of lysozyme‐chitosan oligosaccharide conjugates (LYZOX) against Streptococcus gordonii and Porphyromonas gingivalis . Materials and Methods Planktonic S. gordonii and P. gingivalis were treated with various concentrations of LYZOX for 10 min. The treated bacteria were incubated on trypticase soy agar plates, and colony‐forming unit (CFU) was calculated. The antibacterial effect of LYZOX was compared with that of lysozyme, chitosan, physiological saline, and benzalkonium chloride solution. Cell morphology before and after LYZOX treatment was observed using a scanning electron microscope (SEM). The antibacterial effect of LYZOX with decanoic acid against the biofilm‐like bacteria was also examined via crystal violet staining. The Kruskal–Wallis test and post hoc Dunn tests were performed to compare the difference in antibacterial activity of each treatment.
Results
Bacterial CFU numbers were reduced after LYZOX treatment in a concentration‐dependent manner. The reduction in CFUs was smaller for corresponding concentrations of chitosan or lysozyme alone. SEM analyses revealed bacterial cells shrank following LYZOX treatment. The combined use of LYZOX and decanoic acid yielded an even higher antibacterial effect against bacterial biofilms.
Conclusion
LYZOX exhibits antibacterial activity against two periodontal bacteria and may be a promising plaque control agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
- Department of Lifetime Oral Health Care Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
- Department of Oral Diagnosis and General Dentistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
- Oral Care Periodontics Center, Southern TOHOKU Research Institute for Neuroscience, Southern TOHOKU General Hospital, Koriyama, Japan.
ORCID-Profile: Yasuo Takeuchi
Förderung
- Wako Filter Technology Co., Ltd.
Zitieren
APA
Takeuchi, Y., Nemoto, T., Kitanaka, Y., Aoki, A., Izumi, Y., Iwata, T., & Arakawa, S. (2024). Antibacterial activity of lysozyme‐chitosan oligosaccharide conjugates on two periodontal bacteria. Oral Diseases. https://doi.org/10.1111/odi.14710
Vancouver
Takeuchi Y, Nemoto T, Kitanaka Y, Aoki A, Izumi Y, Iwata T, et al. Antibacterial activity of lysozyme‐chitosan oligosaccharide conjugates on two periodontal bacteria. Oral Diseases. 2024. doi:10.1111/odi.14710
BibTeX
@article{Takeuchi2024,
author = {Takeuchi, Yasuo and Nemoto, Takashi and Kitanaka, Yutaro and Aoki, Akira and Izumi, Yuichi and Iwata, Takanori and Arakawa, Shinichi},
title = {Antibacterial activity of lysozyme‐chitosan oligosaccharide conjugates on two periodontal bacteria},
journal = {Oral Diseases},
year = {2024},
doi = {10.1111/odi.14710}
}
EUVIMED